Literature DB >> 15380539

The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.

Eric A Elster1, Douglas A Hale, Roslyn B Mannon, Linda C Cendales, S John Swanson, Allan D Kirk.   

Abstract

Organ transplantation has become a standard life-saving therapy for many causes of end stage organ failure. Although valuable, it remains hampered by the requirement for, and complications of, immunosuppression to prevent immune rejection of the transplanted organ. It is now clear that rejection can be avoided in some experimental systems without a requirement of immunosuppressive medication, and these experimental concepts are now making their way into the clinic in the form of early transplantation tolerance trials. This manuscript will discuss the most promising techniques for tolerance induction, namely, costimulation blockade, lymphocyte depletion, and mixed chimerism. Seminal preclinical studies will be cited and the results of initial clinical trials will be reviewed. The data to date indicate that while tolerance remains elusive, immunosuppression minimization is a feasible near-term alternative.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380539     DOI: 10.1016/j.trim.2004.05.010

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  10 in total

Review 1.  Chronic allograft nephropathy in paediatric renal transplantation.

Authors:  Stephen I Alexander; Jeffrey T Fletcher; Brian Nankivell
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

2.  Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire.

Authors:  Weldy V Bonilla; Markus B Geuking; Peter Aichele; Burkhard Ludewig; Hans Hengartner; Rolf M Zinkernagel
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

Review 3.  T cell tolerance induced by therapeutic antibodies.

Authors:  Stephen P Cobbold
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

4.  Dissociation between peripheral blood chimerism and tolerance to hindlimb composite tissue transplants: preferential localization of chimerism in donor bone.

Authors:  Dina N Rahhal; Hong Xu; Wei-Chao Huang; Shengli Wu; Yujie Wen; Yiming Huang; Suzanne T Ildstad
Journal:  Transplantation       Date:  2009-09-27       Impact factor: 4.939

5.  IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.

Authors:  Shana M Coley; Mandy L Ford; Samantha C Hanna; Maylene E Wagener; Allan D Kirk; Christian P Larsen
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

Review 6.  Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

Authors:  Dela Golshayan; Manuel Pascual
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  An effective approach to prevent immune rejection of human ESC-derived allografts.

Authors:  Zhili Rong; Meiyan Wang; Zheng Hu; Martin Stradner; Shengyun Zhu; Huijuan Kong; Huanfa Yi; Ananda Goldrath; Yong-Guang Yang; Yang Xu; Xuemei Fu
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

8.  CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.

Authors:  Christoph Jochum; Mechthild Beste; Eustacia Zellmer; Scott S Graves; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2007-02       Impact factor: 5.742

9.  The evolving role of alemtuzumab (Campath-1H) in renal transplantation.

Authors:  Phuong-Thu T Pham; Gerald S Lipshutz; Phuong-Truc T Pham; Joseph Kawahji; Jennifer S Singer; Phuong-Chi T Pham
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

10.  The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.

Authors:  Renaud Snanoudj; Carlos Frangié; Benjamin Deroure; Hélène François; Caroline Créput; Séverine Beaudreuil; Antoine Dürrbach; Bernard Charpentier
Journal:  Biologics       Date:  2007-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.